ProfileGDS4718 / 200925_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 99% 99% 98% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 98% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 98% 99% 99% 99% 99% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]13.120499
GSM549102patient 115, normal, homogenized [OPG study]13.13699
GSM549104patient 119, normal, homogenized [OPG study]11.83398
GSM549108patient 138, normal, homogenized [OPG study]13.082699
GSM549119patient 077, normal, homogenized [OPG study]13.057799
GSM549133patient 032, cancer, homogenized [OPG study]12.771399
GSM549139patient 042, cancer, homogenized [OPG study]12.64699
GSM549099patient 107, normal, homogenized [OPG study]13.288699
GSM549109patient 139, normal, homogenized [OPG study]12.99199
GSM549110patient 046, normal, homogenized [OPG study]13.463199
GSM549114patient 063, normal, homogenized [OPG study]13.270699
GSM549122patient 082, normal, homogenized [OPG study]12.923799
GSM549134patient 033, cancer, homogenized [OPG study]13.086299
GSM549136patient 036, cancer, homogenized [OPG study]12.46499
GSM549140patient 044, cancer, homogenized [OPG study]12.656299
GSM549111patient 047, normal, homogenized [OPG study]13.003699
GSM549113patient 057, normal, homogenized [OPG study]13.480199
GSM549132patient 031, cancer, homogenized [OPG study]12.319399
GSM549137patient 038, cancer, homogenized [OPG study]12.866299
GSM549142patient 047, cancer, homogenized [OPG study]11.220798
GSM549100patient 110, normal, homogenized [OPG study]13.211199
GSM549107patient 135, normal, homogenized [OPG study]13.15599
GSM549115patient 068, normal, homogenized [OPG study]13.353599
GSM549116patient 072, normal, homogenized [OPG study]13.352799
GSM549120patient 078, normal, homogenized [OPG study]12.821599
GSM549131patient 030, cancer, homogenized [OPG study]12.699499
GSM549118patient 074, normal, homogenized [OPG study]13.245799
GSM549129patient 027, cancer, homogenized [OPG study]11.969199
GSM549123patient 088, normal, homogenized [OPG study]12.550599
GSM549124patient 006, cancer, homogenized [OPG study]12.454799
GSM549126patient 015, cancer, homogenized [OPG study]12.647699
GSM549128patient 025, cancer, homogenized [OPG study]12.244599
GSM549103patient 117, normal, homogenized [OPG study]12.781799
GSM549117patient 073, normal, homogenized [OPG study]13.186899
GSM549138patient 041, cancer, homogenized [OPG study]12.421599
GSM549141patient 045, cancer, homogenized [OPG study]12.920799
GSM549130patient 028, cancer, homogenized [OPG study]12.341299
GSM549101patient 111, normal, homogenized [OPG study]12.898199
GSM549105patient 128, normal, homogenized [OPG study]13.09999
GSM549106patient 134, normal, homogenized [OPG study]11.862898
GSM549112patient 048, normal, homogenized [OPG study]13.411799
GSM549125patient 011, cancer, homogenized [OPG study]12.594799
GSM549127patient 024, cancer, homogenized [OPG study]12.363399
GSM549135patient 035, cancer, homogenized [OPG study]12.73199